These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19700160)

  • 1. Utilization of lipid lowering medications among adults in the United States 1999-2006.
    Li M; Ong KL; Tse HF; Cheung BM
    Atherosclerosis; 2010 Feb; 208(2):456-60. PubMed ID: 19700160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS).
    Zhao S; Wang Y; Mu Y; Yu B; Ye P; Yan X; Li Z; Wei Y; Ambegaonakr BM; Hu D;
    Atherosclerosis; 2014 Aug; 235(2):463-9. PubMed ID: 24950001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
    Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Becoming more "goal-oriented" in therapy of dyslipidemias: results of the Hungarian MULTI GAP 2010].
    Reiber I; Paragh G; Márk L; Pados G
    Orv Hetil; 2011 May; 152(21):822-7. PubMed ID: 21546340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
    Ghandehari H; Kamal-Bahl S; Wong ND
    Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
    Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
    Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypercholesterolemia in patients with diabetes at a family practice office.
    Camenga D; Gill JM
    Del Med J; 2003 Nov; 75(11):415-20. PubMed ID: 14870630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of statins in the treatment of diabetic dyslipidemia.
    Berriche O; Amrouche C; Jamoussi H; Blouza S
    Tunis Med; 2010 Feb; 88(2):80-4. PubMed ID: 20415163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.
    Waters DD; Brotons C; Chiang CW; Ferrières J; Foody J; Jukema JW; Santos RD; Verdejo J; Messig M; McPherson R; Seung KB; Tarasenko L;
    Circulation; 2009 Jul; 120(1):28-34. PubMed ID: 19546386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.
    Devroey D; Velkeniers B; Duquet W; Betz W
    Int J Cardiol; 2005 May; 101(2):231-5. PubMed ID: 15882669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of therapeutic lipid target achievements among high-risk patients in Oman.
    Al-Waili K; Al-Zakwani I; Al-Dughaishi T; Baneerje Y; Al-Sabti H; Al-Hashmi K; Farhan H; Habsi KA; Al-Hinai AT; Al-Rasadi K
    Angiology; 2014 May; 65(5):430-5. PubMed ID: 23564019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrates but not statins increase plasma selenium in dyslipidemic aged patients--the EVA study.
    Arnaud J; Akbaraly TN; Hininger-Favier I; Berr C; Roussel AM
    J Trace Elem Med Biol; 2009; 23(1):21-8. PubMed ID: 19203713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
    Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: the di@bet.es study.
    Martinez-Hervas S; Carmena R; Ascaso JF; Real JT; Masana L; Catalá M; Vendrell J; Vázquez JA; Valdés S; Urrutia I; Soriguer F; Serrano-Rios M; Rojo-Martínez G; Pascual-Manich G; Ortega E; Mora-Peces I; Menéndez E; Martínez-Larrad MT; López-Alba A; Gomis R; Goday A; Girbés J; Gaztambide S; Franch J; Delgado E; Castell C; Castaño L; Casamitjana R; Calle-Pascual A; Bordiú E
    Clin Investig Arterioscler; 2014; 26(3):107-14. PubMed ID: 24461346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China.
    Ouyang XJ; Zhang YQ; Chen JH; Li T; Lu TT; Bian RW
    Chin Med J (Engl); 2018 Feb; 131(3):295-300. PubMed ID: 29363644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering agents.
    Ewang-Emukowhate M; Wierzbicki AS
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):401-11. PubMed ID: 23811423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.